Search
Patexia Research
Case number 1:23-cv-00848

Boehringer Ingelheim Pharmaceuticals Inc. et al v. Boehringer Ingelheim Corporation et al > Documents

Date Field Doc. No.Description (Pages)
Sep 12, 2023 9 CONSENT JUDGMENT (CASE CLOSED) Signed by Judge Colm F. Connolly on 9/12/2023. Associated Cases: 1:23-cv-00847-CFC, 1:23-cv-00848-CFC, 1:23-cv-00849-CFC(nmf) (Entered: 09/12/2023) (5)
Sep 12, 2023 10 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,949,998 B2; 10,258,637 B2; 11,090,323 B2. (Attachments: # 1 Consent Judgment)(nmf) (Entered: 09/12/2023) (0)
Aug 30, 2023 8 PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 08/30/2023) (5)
Aug 10, 2023 7 STANDING ORDER REGARDING BRIEFING IN ALL CASES Associated Cases: 1:23-cv-00847-CFC, 1:23-cv-00848-CFC, 1:23-cv-00849-CFC(nmf) (Entered: 08/10/2023) (2)
Aug 9, 2023 N/A Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:23-cv-00847-CFC, 1:23-cv-00848-CFC, 1:23-cv-00849-CFC (rjb) (Entered: 08/09/2023) (0)
Aug 4, 2023 1 Complaint* (1)
Aug 4, 2023 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 08/07/2023) (3)
Aug 4, 2023 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/17/2022. Date of Expiration of Patent: See Attached. (vfm) (Entered: 08/07/2023) (1)
Aug 4, 2023 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,949,998 B2 ;10,258,637 B2 ;11,090,323 B2. (vfm) (Entered: 08/07/2023) (1)
Aug 4, 2023 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (vfm) (Entered: 08/07/2023) (2)
Aug 4, 2023 6 Summons Issued as to Ajanta Pharma Limited on 8/4/2023. (vfm) (Entered: 08/07/2023) (2)
Menu